Get notified of page updates

Categories Racial and Ethnic Differences

FORCE's eXamining the Relevance of Articles for You (XRAY) program looks behind the headlines of cancer news to help you understand what the research means for you. XRAY is a reliable source of hereditary cancer research-related news and information.

Search XRAY

reset
reset search

Search Results for Categories Racial and Ethnic Differences page 4

Showing 31 through 33 out of 33

Relevance: Medium-High

Most relevant for: African American women who have been diagnosed with breast cancer

Study: Racial disparities in BRCA testing: Why?

Black women receive BRCA testing less frequently than white women. Why is that? Researchers thought the reason might be that black and white women see different health care providers. However, new research suggests that disparities in physician recommendations for testing are the cause: black women with breast cancer were less likely to receive physician recommendations for BRCA testing than white women with breast cancer. There is a need to ensure equity in physician testing recommendations for black women. (7/21/16)

READ MORE  ›

Relevance: High

Most relevant for: Young black women who have been diagnosed with breast cancer

Study: BRCA mutations more common than expected in young black women with breast cancer

Most estimates of the percentage of breast cancer patients with mutations in BRCA are based on studies in White women. These researchers found that Black women diagnosed at a young age with breast cancer were twice as likely to have a BRCA mutation than previously reported based on studies in White women with breast cancer diagnosed in the same age categories. This study shows how important it is for all Black women diagnosed with breast cancer before age 50 to speak with their doctor about genetic counseling and testing. (9/29/15)

READ MORE  ›

Relevance: Medium-High

Most relevant for: Women diagnosed with DCIS

Study: All DCIS is not the same: Young women and African American women at higher risk after DCIS diagnosis

Diagnoses of ductal carcinoma in situ (DCIS), sometimes called stage 0 breast cancer, have increased in recent decades. Many people with DCIS wonder if they need aggressive treatment. A study looking at the survival of over 100,000 women found that breast cancer mortality after DCIS is low (3%), and identified groups of women who are at higher risk after DCIS. (9/8/15)

READ MORE  ›